Post on 21-Apr-2017
Xin-Min Li, MD, PhD, FRCPCProfessor and Chair, Department of PsychiatryCapital Health Chair in Mental Health ResearchSpecial Advisor on China Research Initiatives,
University of Alberta, Canada
Department of Psychiatry
White Matter Deficits: New TMS Treatment Targets in Depression?
Without emotion, man would be nothing but a biological computer. Love, joy, sorrow, fear, apprehension, anger, satisfaction, and discontent provide the meaning of human existence.
------------Arnold M. Ludwig (1980)
Samuel Clemens(Mark Twain)
Ernest Hemingway
Peter Tchaikovsky Robert Schumann Kurt Cobain
Alexander Pushkin
Vincent Van Gogh
Virginia Woolf
* 17/3/2017
Adapted from Health Statistics and Informatics 2004
Ten leading causes of burden of disease World, 2004 and 2030
* 17/3/2017
Lifetime risk: 1 in 6 individuals in the United States, 1 in 10 in Canada
Core symptoms:Depressed mood, anhedonia, irritability, difficulties in concentrating, and abnormalities in appetite and sleep
High mortality associated with suicide
Treatment: Psychotherapy (cognitive therapy, interpersonal therapy)
Social supports (family and friends et al)
Antidepressants treatment
Brain stimulations (ECT, rTMS, DBS et al)
Alternative Therapy (Light therapy, herbal et al)
Quick facts of depression
* 17/3/2017
* 17/3/2017
* 17/3/2017
* 17/3/2017
* 17/3/2017
* 17/3/2017
* 17/3/2017
* 17/3/2017
In the limbic (emotional) regions of the brain, that are primarily responsible for depression, there is a relative deficit in:
Noradrenaline (NA),Serotonin (5-HT)Possibly dopamine (DA)(Leonard and Healy, 1999)
Acute action of antidepressants that were available resulted in the “monoamine hypothesis”
Monoamine Hypothesis of Depression
* 17/3/2017
Serotonin and Norepinephrine in the brain
Limbic System
Locus Ceruleus (NE Source)
Prefrontal Cortex
Raphe Nuclei (5-HT source)
Cooper JR, Bloom FE. The Biochemical Basis of Neuropharmacology. 1996.
* 17/3/2017
Two sides to the neurotransmitter theory
Sex
Appetite
Aggression
Concentration
Interest
Motivation
Depressed Mood
Anxiety
Irritability
Thought process
References:1. Adapted from: Stahl SM. In: Essential Psychopharmacology: Neuroscientific Basis and Practical Applications: 2nd ed. Cambridge University Press 2000.
2. Blier P, et al. J Psychiatry Neurosci. 2001;26(1):37-43.3. Doraiswamy PM. J Clin Psychiatry. 2001;62(suppl 12):30-35.4. Verma S, et al. Int Rev Psychiatry. 2000;12:103-114.
Norepinephrine (NE)
• Both serotonin and norepinephrine mediate a broad spectrum of depressive symptoms
Serotonin (5-HT)
Vague Aches and pain
Functional domains of Serotonin and Norepinephrine1-4
* 17/3/2017
2-3 week lag period for therapeutic responseMonoamine depletion does not produce depressive symptoms in healthy individualsPET studies fail to show the reduced receptor and transporter numbersGenetic association analyses shows no evidence of monoaminergic gene involvement in depressionThe chronic effects of antidepressantsNeurotrophic and neurogenesis hypothesis
Challenges to traditional theories
Am J Psychiatry 167:11, 2010
* 17/3/2017
The brain is a dynamic system that derives its structural and functional capacity from the interaction of genes and environmental factors.Neuroplasticity describes the ability of the brain to undergo functioning-relevant adaptations to external or internal stimuli.Depression occurs when the processes involved in maintaining structural plasticity are impaired (e.g., changes in neurotransmitter concentrations, receptor activity, synaptic cascades).
Depression is a disorder of neuroplasticity
* 17/3/2017
Depression, in part, results from a loss of neurotrophic support that leads to:
atrophyloss of neurons in the brain
Suggests that the etiology and treatment of depression will involve alterations in:
structureneurochemicals
Antidepressants act, in part, by inducingneurotrophic effects that reverse structural changes that have occurred.
Neurotrophic hypothesis
* 17/3/2017
Hippocampal volume is decreased in patients with depression • is related to duration of depression*• antidepressant treatment partially blocks or reverses
the hippocampal volume reduction**
In depressed patients, volumes are decreased in:• amygdala core nuclei †• subgenual prefrontal cortex ††
Structural alterations in depression
*Sheline et al., Proc Natl Acad Sci. USA 996;93:3908 Sheline et al., J Neurosci. 1999;19:5034 MacQueen et al., 2003
** Sheline et al., Am J Psych. 2003;160(8):1 Vermetten et al., Biol Psych. 2003;54:693 † Sheline et al., Neuroreport. 1998;9:2023†† Drevets et al., Nature 1997;386:824
* 17/3/2017
Sheline YI et al., J Neurosci. 1999;19:5034-5043
Hippocampus and Depression
0 500 1000 1500 2000 2500 3000 3500 4000
Tota
l Hip
poca
mpa
l Vol
ume,
mm
3
5800
5300
4800
4300
3800
3300
2800
Time Depressed, Days
Correlation between duration of depression and hippocampal volume
* 17/3/2017
• In adult animals, new neurons are formed continuously from progenitor cells located in the subgranular zone (SGV)• Those neurons differentiate and become incorporated into neuronal circuits in the dentate gyrus
Hippocampal Neurogenesis
Warner-Schmidt and Duman (2006) Hippocampus 16: 239
* 17/3/2017
Antidepressant treatment increases neurogenesis
Santarelli et al. 2003 Science 301(5634): 805-809.
Dranovsky and Hen 2006 Biological Psychiatry 59(12): 1136-1143.
Antidepressants induce the Expression of BDNF and FGF in cortical and Hippocampal Neurons
Reviewed by Turner, Akil et al. 2006 Biological Psychiatry 59(12): 1128-1135.
Reviewed by Tardito, Perez et al. 2006 Pharmacol Rev 58(1): 115-134.
Stress and Neurogenesis
Biological Psychiatry (2006), 59. 1116-1127
* 17/3/2017
Biologicalrisks
Stressors
Limbic-cortical circuits
Depressiveepisode
Treatment
Homeostasis
Phenotype Dimensional characteristics?
Categorical subtypes?
Environment Early abuse Life events Medical illness
Gender Family history Temperament HPA reactivity Specific genes
Conceptual Model of Depression
* 17/3/2017
White matter hyperintensities (WMHs) are areas of increased signal intensity on T2 weighted MRIs.
A higher rate and severity of WMHs in individuals with late life depression compared with healthy elderly controls.
WMHs also found in early onset depression recently
WMHs are due to three major causes: dilated perivascular spaces, oligemic demyelination and ischemic demyelination.
Oligodendrocyte dysfunctions in MDD
review in Journal of Neurology, Neurosurgery, and Psychiatry (2008);79:619-624. Ann N Y Acad Sci. (2002) Nov;977:333-9. Biological Psychiatry. (2001), 50:179-183.
* 17/3/2017
Forest plots of cross-sectional analyses comparing (A) overall white matter hyperintensities (WMH), (B) deep WMH, and (C) periventricular WMH on depression.
Journal of Psychiatric Research, Volume 56, 2014, 56–64
White Matter Hyperintensities on Depression
* 17/3/2017
Journal of Psychiatric Research, Volume 56, 2014, 56–64
White Matter Hyperintensities on Depression
Forest plots of longitudinal (A) and cross-sectional (B) studies comparing volumetric assessment of overall white matter hyperintensities and depression.
* 17/3/2017
(A) Lateral view of the cortical surface of the brain, showing the dorsolateral prefrontal cortex (dlPFC), ventrolateral PFC (vlPFC), orbitofrontal cortex (OFC), and insular cortex (ins). (B) Mid‐sagittal view of the brain, showing the medial PFC (mPFC), anterior cingulate cortex (subgenual (sgACC), rostral (rACC), dorsal (dACC)), striatum (stria), amygdala (Am), and hippocampus (Hp).
Brain Regions Implicated as Potential Illness and Treatment Biomarkers in MDD
Annals of the New York Academy of Sciences (2015) Volume 1344, Issue 1, pages 50-65.
* 17/3/2017
Expression of CNPase protein in ventral prefrontal white matter from 14 matched pairs of subjects with major depressive disorder (MDD) and control subjects. Mean values (with S.E.M.) of the normalized optical density for each group are presented.
Journal of Psychiatric Research, Volume 65, 2015, 53–62
Oligodendrocyte Morphometry and Expression of Myelin – Related mRNA in Ventral Prefrontal White Matter in MDD
* 17/3/2017
Oligodendrocyte Dysfunctions in MDD
Molecular Psychiatry (2005) 10, 309–322.
Major depressive disorder may be associated with changes in cell communication and signal transduction mechanisms that contribute to abnormalities in oligodendrocyte and synaptic function.
* 17/3/2017
Reduced oligodendrocyte are found in various brain areas in MDD
Oligodendrocyte Dysfunctions in MDD
Biological Psychiatry (2004) 55, 563-569Schizophrenia Research (2007) 94, 273-280Neuroscience (1999) 91, 1247-1255
* 17/3/2017
Psychiatry Research (2007)151: 179-188
(A) Normal control subject(B) Normal control subject(C) Schizophrenic subject(D) Bipolar disorder subject(E) Major depression subject
A C D E
The density and size of oligodendrocytes reduced in patients with SCZ and depression
* 17/3/2017
Depression is the commonest psychiatric comorbidity in Multiple Sclerosis (MS) patients– Point prevalence rates for major depressive syndromes in MS clinic populations are in the range of 14%
– Lifetime risk for MDD in the MS population may be as high as 50%
– Almost all comparison studies have reported higher rates of depression among MS patient cohorts than among those with other chronic illnesses, including other neurologic disorders
Medical intervention may increase depression– Corticosteroids, beta interferons
Depression in Multiple Sclerosis
Mult Scler Relat Disord. 2016 Jan;5:12-26; Multiple Sclerosis (2005) 11: 328-337
* 17/3/2017
Antidepressant treatment partially blocks or reverses the memory impairment and hippocampal volume reduction
Antidepressants and Structural Alterations in Depression
Sheline et al., Am J Psych. 2003;160(8):1; Vermetten et al., Biol Psych. 2003;54:693
* 17/3/2017
* Malberg et al., J Neurosci. 2000;20:9104** Manev et al., Eur J Pharmacol.
2001;411:67
Studies from several laboratories have reported increased neurogenesis in adults treated with
SSRI, SNRI, MAOI, ECT*SSRI and atypical antidepressants**SSRI and tricyclic antidepressants†
Atypical antipsychotics ††
Antidepressant Treatment Increases Neurogenesis
† Santarelli et al., Science 2003;302:805-809 †† Madsen et al., Biol Psychiatry 2000;47:1043
* 17/3/2017
Do oligodendrocyte dysfunctions play their roles in Depression pathogenesis?
Contributions to the disease onset and development
Interaction between stress and oligodendrocyte dysfunction
Will interventions work on depression influence the function of oligodendrocyte cells?
Questions
* 17/3/2017
Therapeutic Potential on White Matter Deficits in The Treatment of MDD-
preclinical Studies
* 17/3/2017
• Cuprizonecopper chelator produces copper deficiency in mice demyelinationcan be added to feed
• Cuprizone administrationdemyelination and apoptosis of oligodendrocytescessation of cuprizone results in remyelination within 3-4 weeks demyelination and remyelination can be manipulated
• dose of cuprizone • duration of administration
Cuprizone
Animal Model – Cuprizone-induced Demyelination
* 17/3/2017
(Brain Pathol., 2003; 13:329-339)
Two-way ANOVA & Newman-Keuls Test **p< 0.01 vs. Con; +p<0.05 ++p< 0.01 vs. cup
Y-maze results
• Quetiapine protects from cuprizone-inducedSpatial working memory impairment in mice
Department of Psychiatry
* 17/3/2017
Magnification: 10x
LFB-PAS staining Corpus Callosum MBP staining Cerebral CortexNormal
• Protects Mice from Cuprizone-Induced Demyelinationdecreased LFB-PAS in corpus callosumdecreased MBP staining in cortex
Quetiapine (10mg/kg/day)
Cuprizone (0.2%w/w) Cuprizone+quetiapine
Normal Quetiapine (10mg/kg/day)
Cuprizone (0.2%w/w) Cuprizone+quetiapine
Quetiapine Prevents Demyelination
* 17/3/2017
Zhang, et al., 2008
Two-way ANOVA & Newman-Keuls Test **P< 0.01 vs. Control; ++P< 0.01 vs. Cuprizone
• Cuprizone causes enlargement of lateral ventricles• Quetiapine prevented the enlargement of lateral ventricle
Quetiapine (10mg/kg/day)Normal
Cuprizone (0.2%w/w) Cuprizone+quetiapine
Quetiapine prevents ventricle enlargement
* 17/3/2017
PhotomicrographsA: Control B: DM-12w C: DM-12w -- RM-2w (W) D: DM-12w -- RM-2w (Q)E: DM-12w -- RM-3w (W) F: DM-12w -- RM-3w (Q) G: DM-12w -- RM-4w (W) H: DM-12w -- RM-4w (Q) W: water Q: quetiapine Bar: 200μm
Quetiapine Promotes MBP Expression in Cerebral Cortex of Demyelinated Brain
* 17/3/2017
Zhang, et al 2012
*P < 0.05; **P < 0.01, vs. controls
• Quetipine in normal micestimulates oligodendrocytesdecreases proportion of astrocytes
Quetiapine Increases Oligodendrocytes
Xiao, et al., Molecular psychiatry,2008* 17/3/2017
Initialization of myelination
Myelin lamella Myelinated axon
• Quetiapine facilitates myelination in aggregating neocortical cell cultures
Quetiapine in Neocortical Cell Cultures
Xiao, et al., 2008
* 17/3/2017
The Effects of Transcranial Magnetic Stimulation (rTMS)
on White Matter Deficits
* 17/3/2017
rTMS is a procedure in which cerebral electrical activity is influenced by a pulsed magnetic field
Transcranial magnetic stimulation (TMS)*
Major depression, Schizophrenia, Addition, Stroke Parkinson’s Disease
* 17/3/2017
Mechanisms to treat depression are still not fully clearAn hypothesis is that the effects of rTMS on the brain are long-term depression (LTD)-or long-term potentiation (LTP)-like, as the duration of the effects seems to implicate the changes in synaptic plasticity.
Mechanisms may exist in:
Regulating the endocrinological response of the HPA axis
Effects on neurotransmitter systems in major depression
Affecting neurotrophic factors in the brain
inducing neurogenesis in the brain
Mechanism of rTMS
* 17/3/2017
Hypothesis
White Matter Dysfunction
MDD
rTMS ?
rTMS may improve the function of white matter and oligodendrocytes in the brain of MDD patient
* 17/3/2017
Cuprizone
Animal Model – Cuprizone-induced Demyelination
Co-treatment with cuprizone and rTMS for 3-6 weeks Behavioural tests White matter pathology Genetic and molecular reactions to rTMS treatment Fourier transform infrared (FT-IR) microspectroscopy for white matter repair and molecular reformation
* 17/3/2017
Effect of HF-rTMS on CPZ-induced Y-Maze Spontaneous Alteration
Effect of HF-rTMS on CPZ-induced Y-Maze spontaneous alteration. (A): Experimental 1 (acute phase); (C): Experimental 2 (recovery phase); Experimental 3 (chronic phase) Results are expressed as mean ± SEM of 16 mice in each group. #P<0.05 vs. Sham group;*P<0.05 vs. CPZ group
* 17/3/2017
rTMS Improves Social Interactions
The effect of HF-rTMS on CPZ-induced social interaction behavior. (A): Experimental tracking chart; (B): Experiment 1 (acute phase) (a): Session 1; (b): Session 2; (C): Experiment 2 (recovery phase) (c): Session 1; (d): Session 2; (D) Experiment 3 (chronic phase) (e): Session 1; (f): Session 2. Results are expressed as mean ± SEM of the 16 mice in each group. Session 1:#P<0.05 vs. empty cup;*P<0.05 vs. strange1; Session 2: $P<0.05 vs.strange1; %P<0.05 vs.strange2;
* 17/3/2017
rTMS Alleviates Demyelination
(A) Luxol fast blue and periodic acid Schiff (LFB-PSA) staining for phospholipid of myelin sheaths from Bregma 0.86mm - 0.38mm [A.(1)] and [A.(2),(3)] are shown using low and high magnification (4X and 20X) respectively. Myelination score of ec and cp areas are represented in A (4), (5).
* 17/3/2017
rTMS Alleviates Demyelination(B) MBP immunostaining in cortical area Bregma 0.86mm - 0.38mm. [B. (1)] and [B. (2)] are shown using low and high magnification (4X and 20X) respectively. MBP western blotting in cortical area B. (3); (C) MBP immunostaining in hippocampus area from Bregma -1.46mm -2.18mm.[C.(1)] and [B.(2)] are shown using low and high magnification (4X and 20X) respectively. MBP western blotting in hippocampus area C.(3); Results are expressed as mean ± SEM of 8 mice in each group. #P<0.05 vs.Sham group;*P<0.05 vs. CPZ group. 1: Sham; 2: CPZ; 3: Sham + rTMS; 4: CPZ + rTMS; cg: cingulum; ec: external capsule; cp: caudate putamen (striatum) LV: lateral ventricle; ctx: cortex; DG: dentate gyrus;
* 17/3/2017
Effect of HF-rTMS on PDGFαexpression in prefrontal cortex and hippocampus after 6 weeks of CPZ
(A) PDGFα-immunostaining in ec (A.1), cg (A.2), and DG (A.3) areas. Western blotting in prefrontal cortex (B) and hippocampus (C). Results are expressed as mean ± SEM of 8 mice in each group. #P<0.05 vs.Sham group; *P<0.05vs. CPZ group.1: Sham; 2: CPZ; 3: Sham+rTMS; 4: CPZ+rTMS; cg: cingulum; ec:external capsule; DG: dentate gyrus
* 17/3/2017
The Effect of HF-rTMS on GFPA and CD11b Expression in Cortex and Hippocampus after 6 Weeks of CPZ
(A):immunofluorescent staining for GFAP inBregma0.86mm-0.38mm[A.(1)]and [A.(3)] are represented the 4×,and 20× magnificationrespectively. [A.(2)] are represented the DG area. Western blotting of GFAP, CD-11b in cortex and hippocampus (B, C).Results are expressed as mean± SEM of 8mice in each group. 1: Sham; 2: CPZ; 3: Sham+rTMS; 4: CPZ+rTMS;#P<0.05 vs.Sham group;*P<0.05vs. CPZ group.
* 17/3/2017
Myelination, Oligodendrocytes, and Serious Mental Illness
Haroutunian, et al., 2015
* 17/3/2017
Involvement of oligodendrocyte degeneration in pathophysiology of MDD
decrease in white matter volume• loss of oligodendrocytes• down-regulation of myelin genes• lesions in the white matter may be treatment resistant MDD
Quetiapine and rTMS• increases oligodendrocytes and reduces astrocytes in normal
mice• prevents demyelination caused by cuprizone• prevents behaviour impairments• The oligodendrocyte genesis as a potential target in the
treatment of MDD
Summary
* 17/3/2017
Bench & Bedside White matter deficits and environmental interactions through disease progress
Impact of pharmacological and non-pharmacological treatments on white matter deficits in patient
Apply preclinical study to demyelinating diseases
White matter deficits Vs. neurogenesis theory
White matter deficit in pharmacogenomic and neuroimaging
New treatment focusing on white matter in future?
In Future……
* 17/3/2017
Department of Psychiatry
CIHR, CPRF, MHRC, Schizophrenia Society, NSFC,中国科技部中加科技合作项目(CIHR-MOST)CollaboratorsDrs. Yanbo Zhang, Jiming Kong, Jue He, Haiyun Xu, Lan Xiao, Dai Zhang, Qingrong Tan, Zhijun Zhang, Qingjun Huang
Postdoctoral Fellows and StudentsDrs., Kelly Hartle, Handi Zhang, Junhui Wang, Shufang Feng, Shenghua Zhu
Acknowledgements
* 17/3/2017